Electronic + no text message
DeviceElectronic monitor is attached but no text-messages are sent through cellular phones
Other names: Electronic monitor without text messages
NCT Number: NCT00535769
The purpose of this study is to determine if using an electronic reminder improves adherence to sunscreen use. The specific study aims are as follows:
1. To determine whether the use of electronic reminder system increases adherence to topical agents. 2. To assess technological feasibility of measuring adherence to topical agents using electronic monitors specially designed for tubes. 3. To assess technological feasibility of providing electronic reminders using cellular phone text-messaging system. 4. To obtain subjects' feedback on the adherence monitoring and reminder system.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Early Phase 1
Brigham and Women's Hospital, Boston, Massachusetts, United States
We propose to use communication technology to develop a novel means of monitoring and improving adherence to topical agents. We will conduct a randomized, single-blinded, controlled trial to assess the impact of automated reminder system on adherence rates to sunscreens. This study will involve designing an electronic monitoring device specifically for topical agents and creating a platform for an automated reminder system. The electronic monitoring devices will be adaptable to tubes of varying shapes and sizes, and they will send SMS messages to a central server in real-time each time the tube is opened. We will create a text-message reminder system to send reminders to users' cellular phones over a secured network. Our hypothesis is that the electronic monitoring and reminder system will increase patients' adherence to topical agents. We will measure the impact of the intervention on adherence rates and assess patients' views on the reminder system. This project will allow us to engineer a novel device to electronically monitor adherence to topical agents and to use communication technology to change patients' behavior.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electronic monitor is attached but no text-messages are sent through cellular phones
Other names: Electronic monitor without text messages
Electronic monitor is attached and text messages are sent through cellphone to remind sunscreen use
Other names: Electronic monitor with text message
Time frame: 6 weeks
Participants' adherence was captured in real time using transmitting electronic monitors. At the end of the 6 week trial, the mean number of days the subjects are adherent to using sunscreen were compared.
Time frame: 6 weeks
Patients with the text message reminder system were asked their opinion on their satisfaction/ improved adherence to sunscreen application with the use of the messaging system on a scale of 0 to 10 (0, not useful at all; 10,most useful)
Time frame: 6 weeks
The participants were asked to recall their frequency of sunscreen application based on a 5 point scale (0 never used sunscreen,; 1 forgot to apply 3x weekly,; 2 forgot to apply 1-2x weekly; 3 forgot to apply 1-2x per month; 4 always remembered)
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01535963
Neoplasms, Neoplasms by Site
Chicago, Illinois, United States
View Trial DetailsNCT07670403
Basal Cell Carcinoma of Skin, Behavior
Chengdu, Sichuan, China
View Trial DetailsNCT05313711
Neoplasms, Neoplasms by Site
Aberdeen, United Kingdom
View Trial DetailsNCT05774600
Neoplasms, Neoplasms by Site
Golden, Colorado, United States
View Trial Details